abagovomab 34
abciximab 30
abituzumab 24
abrilumab 22
actoxumab 13
adalimumab 17
aducanumab 12
afasevikumab 17
alacizumab_pegol 11
alemtuzumab 31
alirocumab 22
amatuximab 41
andecaliximab 23
anifrolumab 21
anrukinzumab 17
aprutumab 18
aprutumab_ixadotin 18
arcitumomab 19
ascrinvacumab 7
atezolizumab 16
atinumab 17
avelumab 12
basiliximab 31
bavituximab 37
begelomab 23
benralizumab 30
bevacizumab_beta 22
bezlotoxumab 13
bimagrumab 19
bleselumab 18
blinatumomab 31
blosozumab 29
bococizumab 18
brazikumab 19
brentuximab_vedotin 34
briakinumab 20
brodalumab 11
brolucizumab 28
brontictuzumab 29
burosumab 20
cabiralizumab 30
camrelizumab 14
canakinumab 24
cantuzumab_ravtansin 42
carlumab 15
carotuximab 24
cergutuzumab_amunaleukin2 26
cergutuzumab_amunaleukin 26
certolizumab_pegol 27
cetiximab 43
citatuzumab_bogatox 28
cixutumumab 29
clivatuzumab_tetraxetan 22
codrituzumab 31
conatumumab 14
concizumab 28
crenezumab 22
crizanlizumab 28
crotedumab 22
dacetuzumab 24
daclizumab 18
dalotuzumab 31
dapirolizumab_pegol 26
daratumumab 13
dectrekumab 10
demcizumab 25
denosumab 8
depatuxizumab 24
depatuxizumab_mafodotin 24
dezamizumab 23
dinutuximab 33
diridavumab 21
domagrozumab 17
drozitumab 21
duligotuzumab 20
durvalumab 9
dusigitumab 22
efalizumab 36
efungumab 28
eldelumab 18
elezanumab 21
elgemtumab 13
elotuzumab 17
emactuzumab 21
emapalumab 31
emibetuzumab 20
enavatuzumab 25
enfortumab_vedotin 15
enoblituzumab 17
enokizumab 26
enoticumab 20
ensituximab 35
eptinezumab 16
erenumab 25
etaracizumab 15
etrolizumab 23
evinacumab 23
evolocumab 18
farletuzumab 3
fasinumab 24
fezakinumab 25
fibatuzumab 13
ficlatuzumab 25
firivumab 31
flanvotumab 19
fletikumab 27
foralumab 14
foravirumab 16
fremanezumab 30
fresolimumab 16
fulranumab 20
futuximab 21
galcanezumab 20
ganitumab 21
gantenerumab 14
gemetuzumab 32
gemtuzumab2 27
gemtuzumab 27
gevokizumab 24
girentuximab 31
glembatumumab 19
glembatumumab_vedotin 19
guselkumab 21
ibalizumab 29
ibritumomab 33
icrucumab 12
idarucizumab 31
ifabotuzumab 13
imalumab 18
imgatuzumab 23
inclacumab 21
indatuximab_ravtansin 28
indusatumab 19
inebilizumab 25
intetumumab 15
iodine_girentuximab 29
ipilimumab 8
iratumumab 15
isatuximab 36
itolizumab 22
ixekizumab 32
labetuzumab_govitecan 25
lambrolizumab 31
lampalizumab 27
lanadelumab 19
landogrozumab 19
laprituximab 31
lebrikizumab 37
lendalizumab 27
lenzilumab 18
lifastuzumab_vedotin 24
ligelizumab 23
lilotomab 38
lirilumab 26
lodelcizumab 21
lokivetmab 25
lorvotuzumab_mertansin 23
lucatumumab 31
lumretuzumab 19
lupartumab 18
lutikizumab 19
margetuximab 33
milatuzumab 38
mirvetuximab 35
mirvetuximab_soravtansin 35
modotuximab 41
mogamulizumab 28
monalizumab 24
motavizumab 34
moxetumomab_pasudotox 26
namilumab 24
naratuximab 32
naratuximab_emtansin 32
narnatumab 17
navicixizumab2 28
navicixizumab 27
navivumab 34
necitumumab 10
nemolizumab 27
nesvacumab 17
nivolumab 13
obiltoxaximab 21
obinutuzumab 31
ocaratuzumab 24
ofatumumab 19
olaratumab 18
olokizumab 24
omalizumab 22
onartuzumab 23
ontuxizumab 35
opicinumab 13
orticumab 14
otelixizumab 38
oxelumab 13
ozanezumab 33
pamrevlumab 13
panobacumab 24
parsatuzumab 30
pasotuxizumab 22
pateclizumab 18
patritumab 21
pembrolizumab 31
perakizumab 24
pidilizumab 21
pinatuzumab_vedotin 19
plozalizumab 26
pogalizumab 28
polatuzumab_vedotin 22
ponezumab 34
prezalumab 16
pritoxaximab 36
quilizumab 21
racotumomab 31
radretumab 14
ralpancizumab 23
ramucirumab 13
ranevetmab 31
ranibizumab 22
refanezumab 23
remtolumab 20
rilotumumab 15
rinucumab 17
risankizumab 31
rituximab 24
rivabazumab 24
robatumumab 20
roledumab 33
romosozumab 22
rontalizumab 25
rosmantuzumab 23
rozanolixizumab 23
sacituzumab 29
sacituzumab_govitecan 29
samalizumab 29
sapelizumab 24
sarilumab 17
secukinumab 16
seribantumab 16
setoxaximab 44
sifalimumab 14
siltuximab 20
simtuzumab 29
sirukumab 12
solanezumab 28
solitomab 28
stamulumab 18
suptavumab 22
suvizumab 21
tabalumab 18
tadocizumab 21
tamtuvetmab 35
tanezumab 23
tarextumab 11
tavolixizumab 13
telisotuzumab 31
teplizumab 23
tesidolumab 23
tezepelumab 26
tigatuzumab 16
tildrakizumab 24
timolumab 15
tisotumab 11
tosatoxumab 35
tositumomab 30
tralokinumab 31
trastuzumab 24
tregalizumab 22
trevogrumab 12
ublituximab 28
urelumab 20
ustekinumab 28
utomilumab 26
vadastuximab 29
vadastuximab_talirin 29
vandortuzumab_vedotin 21
vantictumab 20
vanucizumab2 22
vanucizumab 31
varlilumab 17
vatelizumab 19
vedolizumab 28
veltuzumab 17
vesencumab 10
vorsetuzumab 22
vorsetuzumab_mafodotin 22
vunakizumab 31
xentuzumab 17
zatuximab 41
